Antimicrobial Resistance Fighter Coalition - SHEA Guidelines

Prevention of HAIs

The SHEA Guidelines Flipbooks brought to you free of charge courtesy of the Antimicrobial Resistance Fighter Coalition

Issue link: https://eguideline.guidelinecentral.com/i/1059134

Contents of this Issue

Navigation

Page 28 of 31

Reservoirs Î In the healthcare facility, antimicrobial use provides a selective advantage for MRSA to survive. Î The reservoir for MRSA in hospitals includes colonized or infected patients and HCPs as well as contaminated objects within the patient care environment. Transmission is complex but occurs largely through patient-to-patient spread. Basic Practices for Preventing MRSA Transmission and Infection: Recommended for All Acute Care Hospitals Î Conduct a MRSA risk assessment (III). • The risk assessment should be attentive to 2 important factors: the opportunity for MRSA transmission and estimates of the facility-specific MRSA burden and rates of transmission and infection. • Findings from the risk assessment should be used to develop the hospital's surveillance, prevention, and control plan and to develop goals to reduce MRSA acquisition and transmission. Î Implement a MRSA monitoring program (III). • The MRSA monitoring program should have 2 goals: ▶ Identify any patient with a current or prior history of MRSA to ensure application of infection prevention strategies for these patients according to hospital policy (eg, contact precautions). ▶ Provide a mechanism for tracking hospital-onset cases of MRSA for purposes of assessing transmission and infection and the need for response. Î Promote compliance with CDC or WHO hand hygiene recommendations (II). Î Use contact precautions for MRSA-colonized and MRSA-infected patients (II). Î Ensure cleaning and disinfection of equipment and the environment (II). Î Educate HCPs about MRSA (III). Î Implement a laboratory-based alert system that notifies HCPs of new MRSA-colonized or MRSA-infected patients in a timely manner (III). Î Implement an alert system that identifies readmitted or transferred MRSA-colonized or MRSA-infected patients (III). Î Provide MRSA data and outcome measures to key stakeholders, including senior leadership, physicians, nursing staff, and others (III). Î Educate patients and their families about MRSA (III). 27

Articles in this issue

Archives of this issue

view archives of Antimicrobial Resistance Fighter Coalition - SHEA Guidelines - Prevention of HAIs